Karen Eastham, Ronald Matricaria, William Mercer, Matthew Kalnik, Krishnan Nandabalan | GenomeWeb

Karen Eastham has been appointed to the board of directors of Illumina, the company announced last week. She is executive vice president, COO, and a member of the board of trustees of the Burnham Institute. Prior to that, she was senior vice president and CFO of Diversa. Eastham holds an MBA and a BS from Indiana University. She also serves on the boards of directors of Tercica, Oncosis/Cyntellect, and Salmedix, as well on the board of UCSD Athena.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.